General Information of the Compound
Compound ID
CP0468356
Compound Name
5-((5-tert-butyloxazol-2-yl)methylthio)-N-(piperidin-4-ylmethyl)thiazol-2-amine
    Show/Hide
Structure
Formula
C17H26N4OS2
Molecular Weight
366.556
Canonical SMILES
CC(C)(C)c1cnc(CSc2cnc(NCC3CCNCC3)s2)o1
    Show/Hide
InChI
InChI=1S/C17H26N4OS2/c1-17(2,3)13-9-19-14(22-13)11-23-15-10-21-16(24-15)20-8-12-4-6-18-7-5-12/h9-10,12,18H,4-8,11H2,1-3H3,(H,20,21)
    Show/Hide
InChIKey
SELYMTMAYFSILA-UHFFFAOYSA-N
Physicochemical Property
logP
4.1324
Rotatable Bonds
6
Heavy Atom Count
24
Polar Areas
62.98
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44580967
ChEMBL ID
CHEMBL524629
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01235, Cyclin-dependent kinase 9
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000067 HCT 116 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS